Furthermore, RGS5 deletion increased the activation of both the JNK and NF-κB pathways in the adipose tissue, liver and skeletal muscle of obese mice, which are the two critical signaling pathways of inflammation induced by obesity [44]. Here, RGS5 is linked to obesity disorder.